Skip to content

Clinical trials

Phase 3 Bronchiolitis Obliterans Syndrome trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 3 Country / region: South Korea Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20102
20111
20132
20141
20172
20181
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer4
AstraZeneca1
Ewha Womans University Mokdong Hospital1
Hoffmann-La Roche1
Incyte Corporation1
Ipsen1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1
Pharmacyclics LLC.1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome13
Lymphoma, Follicular4
Psoriasis3
Graft vs Host Disease2
Pruritus2
Bone Marrow Diseases1
Bronchitis1
Cholecystitis1
Cholecystitis, Acute1
Emphysema1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.